Patent application number | Description | Published |
20080214554 | Methods for preventing or treating cardiac arrhythmia - Disclosed are methods of preventing or treating cardiac arrhythmia comprising administering to a mammal in need thereof, such as a human, an effective amount of vanoxerine (GBR 12909) or a pharmaceutically acceptable salt, derivative or metabolite thereof. | 09-04-2008 |
20080268472 | High throughput assay systems and methods for identifying agents that alter expression of cellular proteins - Disclosed are high throughput assay systems and methods for identifying agents that alter the level of expression of proteins in mammalian cells, particularly integral membrane proteins. | 10-30-2008 |
20100069403 | Methods for preventing or treating cardiac arrhythmia - Disclosed are methods of preventing or treating cardiac arrhythmia comprising administering to a mammal in need thereof, such as a human, an effective amount of vanoxerine (GBR 12909) or a pharmaceutically acceptable salt, derivative or metabolite thereof. | 03-18-2010 |
20110237604 | METHODS FOR PREVENTING OR TREATING CARDIAC ARRHYTHMIA - Disclosed are methods of preventing or treating cardiac arrhythmia comprising administering to a mammal in need thereof, such as a human, an effective amount of vanoxerine (GBR 12909) or a pharmaceutically acceptable salt, derivative or metabolite thereof. | 09-29-2011 |
20150283131 | PHARMACEUTICAL COMPOSITIONS CONTAINING PIPERAZINE COMPOUNDS IN COMBINATION WITH A P450 INHIBITOR AND METHODS OF TERMINATING ACUTE EPISODES OF CARDIAC ARRHYTHMIA, RESTORING NORMAL SINUS RHYTHM, PREVENTING RECURRENCE OF CARDIAC ARRHYTHMIA AND MAINTAINING NORMAL SINUS RHYTHM IN MAMMALS THROUGH ADMINISTRATION OF SAID COMPOSITIONS - Disclosed embodiments are related to compositions of a piperazine compound and a P450 inhibitor, including compositions of a piperazine compound and one or more P450 inhibitors, and one or more diluents, disintegrants, binders and lubricants, and the processes for their preparation thereof. | 10-08-2015 |
20150290188 | PHARMACEUTICAL COMPOSITIONS CONTAINING ENANTIOMERICALLY PURE AND/OR RACEMIC MIXTURES OF CHIRAL PIPERAZINE COMPOUNDS AND METHODS OF TERMINATING ACUTE EPISODES OF CARDIAC ARRHYTHMIA, RESTORING NORMAL SINUS RHYTHM, PREVENTING RECURRENCE OF CARDIAC ARRHYTHMIA AND MAINTAINING NORMAL SINUS RHYTHM IN MAMMALS THROUGH ADMINISTRATION OF SAID COMPOSITIONS - Disclosed embodiments are related to compositions of a chiral piperazine compounds including compositions comprising enantiomerically pure or racemic mixtures of said piperazine compounds, and one or more diluents, disintegrants, binders and lubricants, and the processes for their preparation thereof. | 10-15-2015 |
20150336917 | NOVEL PIPERAZINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS OF TERMINATING ACUTE EPISODES OF CARDIAC ARRHYTHMIA, RESTORING NORMAL SINUS RHYTHM, PREVENTING RECURRENCE OF CARDIAC ARRHYTHMIA AND MAINTAINING NORMAL SINUS RHYTHM IN MAMMALS - Novel piperazine compounds are disclosed. Also disclosed are pharmaceutical compositions containing these compounds and therapeutic methods of treating cardiac arrhythmias in mammals, particularly humans, including terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm using these compounds. | 11-26-2015 |
20160038482 | VANOXERINE FOR SELF-ADMINISTRATION FOR TERMINATING ACUTE EPISODES OF CARDIAC ARRHYTHMIA IN MAMMALS - Methods of administration of vanoxerine wherein a patient, previously and successfully treated for cardiac arrhythmia with vanoxerine is prescribed a further dose for self-administration of a further dose of vanoxerine for treatment of a subsequent occurrence of cardiac arrhythmia. | 02-11-2016 |